Anti-obesity medications associated with weight rebound post-treatment,suggests study Dr. Kamal Kant Kohli23 July 2025 9:00 AM ISTPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, finds a meta-analysis...
Weight Returns for Many After Stopping Anti-Obesity Drugs: Meta-Analysis Dr. Bhumika Maikhuri23 July 2025 8:00 AM ISTPatients who take anti-obesity medications to aid in weight loss may experience significant weight regain after stopping the drugs, according to a new...
Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study Medha Baranwal19 July 2025 9:15 AM ISTTaiwan: A large-scale cohort study published in JAMA Network Open suggests that the use of GLP-1 receptor agonists, specifically semaglutide and...
GLP-1 RAs Lower Risk of Liver Damage and Death in Alcohol Use, reveals research Dr Riya Dave14 July 2025 9:15 AM ISTResearchers have determined in a new study that the glucagon-like peptide-1 receptor agonists (GLP-1 RAs) lower the risk of alcohol-related liver...
Tirzepatide Shakes Up Obesity Market as Mounjaro Records Rs 390 Mn Sales in June Farhat Nasim11 July 2025 3:05 PM ISTNew Delhi: In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is quickly...
Head-to-head study shows bariatric surgery superior to GLP-1 drugs for weight loss Dr. Kamal Kant Kohli9 July 2025 9:00 PM ISTSleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists...
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment Wegovy Ruchika Sharma9 July 2025 11:36 AM ISTDenmark: Following a recent World Health Organization (WHO) alert on semaglutide-containing medicines, Novo Nordisk has announced the...
Medical Bulletin 04/Jul/2025 Dr. Bhumika Maikhuri4 July 2025 3:00 PM ISTHere are the top medical news for the day:WHO Issues Safety Over Rare Eye Disorder from Semaglutide UseWHO is alerting health-care professionals and...
WHO Issues Safety Over Rare Eye Disorder from Semaglutide Use Dr. Bhumika Maikhuri4 July 2025 8:00 AM ISTWHO is alerting health-care professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION)...
Delhi HC Flags Off-Label Use of Diabetes Drugs for Weight Loss, Seeks CDSCO Report Farhat Nasim3 July 2025 9:27 PM ISTNew Delhi: The Delhi High Court has directed the Central Drugs Standard Control Organisation (CDSCO) and the Drug Controller General of India (DCGI)...
Type 2 diabetes drug improves weight loss, blood sugar in certain Type 1 patients with obesity: Study Dr. Kamal Kant Kohli1 July 2025 8:45 PM ISTA clinical trial led by an Indiana University School of Medicine researcher found that weekly doses of semaglutide - a medication typically prescribed...
